BAT Adds Ex-Apple Counsel Bruce Sewell to Board From 1 January 2027
British American Tobacco named Bruce Sewell, Apple's general counsel from 2009 to 2018, an independent non-executive director effective 1 January 2027. He joins the Audit and Nominations committees as BAT reshapes other board committees on 30 November 2026.
Key points
- BAT appointed Bruce Sewell as an independent non-executive director effective 1 January 2027.
- Sewell was Apple's senior vice president, general counsel and secretary from 2009 to 2018 and spent 14 years at Intel.
- Véronique Laury moves to the Remuneration Committee and Serpil Timuray to the Audit Committee from 30 November 2026.
- Sewell will join both the Audit and Nominations committees when his appointment takes effect.
- BAT Chair Luc Jobin cited Sewell's regulatory and technology background in connection with Horizon 2030.
British American Tobacco will appoint Bruce Sewell, Apple’s general counsel from 2009 to 2018, as an independent non-executive director effective 1 January 2027, the company announced on 28 October 2026.
The underlying document is a BAT board-change announcement made under UK Listing Rule 6.4.6, which requires listed companies to disclose board changes. Kalkine UK reports the rule reference; BAT’s own release text carries the substance of the appointment.
Two committee changes land before Sewell arrives
BAT also set committee moves effective 30 November 2026. Véronique Laury leaves the Audit Committee for the Remuneration Committee, and Serpil Timuray makes the reverse move from Remuneration to Audit. Sewell joins the Audit Committee on 1 January 2027, a month after those switches take effect.
Sewell’s background spans Apple, Intel and two US boards
Sewell held the senior vice president, general counsel and secretary roles at Apple from 2009 to 2018. Before that he spent 14 years at Intel, ending as senior vice president and general counsel. Kalkine UK adds that he was earlier a partner at law firm Brown & Bain PC.
He currently serves as lead independent director of Vail Resorts and as a director of C3.ai. At BAT he will sit on both the Audit and Nominations committees.
| Event | Date | Committee effect |
|---|---|---|
| Véronique Laury and Serpil Timuray swap committees | 30 November 2026 | Laury to Remuneration; Timuray to Audit |
| Bruce Sewell joins the board | 1 January 2027 | Independent non-executive director; Audit and Nominations |
Why a technology lawyer for a tobacco board
BAT Chair Luc Jobin cited Sewell’s work with governments and regulators in the United States, Europe and Asia, his listed-company board experience and his role at an artificial-intelligence company. Jobin linked that background to BAT’s Horizon 2030 ambitions and its stated aim of building a “Smokeless World”, according to Kalkine UK. The announcement gives no detail on any role beyond the two committee seats.
An independent non-executive director is a board member who is not employed by the company and is expected to bring outside judgment to board decisions.
Other leadership posts have changed over 18 months
2FIRSTS reports that BAT has changed or announced changes to its chief financial officer, general counsel, chief marketing officer and APMEA regional leadership over the past 18 months. The same source describes board refreshment through new independent-director appointments and departures. BAT has not tied those moves to the Sewell appointment in the documents reviewed here.
Who is affected and what the documents leave open
Shareholders and analysts tracking BAT’s governance get a new independent voice on the audit and nomination functions from January 2027, with the committee reshuffle landing a month earlier. The appointment itself changes no product rule, licence or tax obligation for retailers or manufacturers.
2FIRSTS also reports that BAT’s Horizon 2030 plan targets mid-teens New Category revenue growth through 2030 and a New Categories contribution margin of at least 30%, with first-half 2026 New Categories revenue up 18.0% and category contribution at £257 million, up 54.7%. Those figures come from 2FIRSTS and are not part of the board announcement reproduced by the primary source.
BAT has not published what Sewell’s committee work will cover beyond the nomination and audit remits, or whether further board changes are planned after 1 January 2027.
Questions readers ask
When does Bruce Sewell join the BAT board?
Sewell joins as an independent non-executive director on 1 January 2027. BAT announced the appointment on 28 October 2026 under UK Listing Rule 6.4.6. He also joins the Audit and Nominations committees on the same date. Two existing directors, Véronique Laury and Serpil Timuray, switch committees earlier, on 30 November 2026.
What did Bruce Sewell do before joining BAT?
Sewell was senior vice president, general counsel and secretary at Apple from 2009 to 2018. Before Apple he spent 14 years at Intel, latterly as senior vice president and general counsel. He is currently lead independent director of Vail Resorts and a director of C3.ai, where Kalkine UK reports he chairs the Nominating and Governance Committee.
Why did BAT pick a former technology general counsel?
BAT Chair Luc Jobin pointed to Sewell's experience with governments and regulators in the United States, Europe and Asia, plus his listed-company board work including at an artificial-intelligence company. Jobin linked that background to BAT's Horizon 2030 ambitions. The announcement does not describe any role for Sewell beyond the Audit and Nominations committees.
Does the appointment affect vaping regulation?
No. The BAT announcement covers board and committee composition only and changes no product rule, licence or tax obligation. Retailers and manufacturers face no new requirement from the appointment itself. Any relevance to nicotine policy sits in Sewell's regulatory background, which BAT's chair cited, not in a change to rules.
Sources
18+ only. This site is for adult readers and provides news and information only. It is not medical, legal or purchase advice. Nicotine is addictive. Always check the official text of any regulation in your market. Health Information